Innospec generated 455600000 in Q4 2025 revenue, down 2% year over year, with net income of 47400000 and diluted EPS of 1.91. Adjusted EBITDA was 55700000, and the company generated 61400000 in cash from operations during the quarter.

Innospec reported relatively stable revenue in Q3 2025 with $441.9 million in net sales while net income and operating income decreased significantly year-over-year amid impairment charges; adjusted earnings per share exceeded expectations. :contentReference[oaicite:0]{index=0}

Innospec delivered modest revenue growth in Q2 2025 with mixed segment performance, modest profitability pressures, and a strong balance sheet.

Innospec Inc. announced its financial results for the first quarter ended March 31, 2025, with total revenues of $440.8 million, a 12% decrease from the prior year. Net income was $32.8 million, or $1.31 per diluted share, and adjusted non-GAAP EPS was $1.42. The company generated $28.3 million in cash from operations and increased its semi-annual dividend by 10% to 84 cents per common share.

Innospec's Q4 2024 results showed a revenue decline of 6% to $466.8 million. The company reported a net loss of $70.4 million, mainly due to a non-cash settlement charge for a UK pension scheme buyout. Adjusted non-GAAP EPS was $1.41, down from $1.84 in Q4 2023. Cash from operations was $25.7 million, closing the quarter with a net cash position of $289.2 million.

Innospec reported Q3 2024 revenues of $443.4 million, a 4% decrease compared to the previous year. Net income was $33.4 million, or $1.33 per diluted share, down from $39.2 million, or $1.57 per diluted share, in the same period last year. Adjusted non-GAAP EPS was $1.35, compared to $1.59 last year. The company generated $73.5 million in cash from operating activities and closed the quarter with $303.8 million in net cash.

Innospec Inc. reported a decrease in revenue by 9 percent to $435.0 million compared to the previous year. Net income increased to $31.2 million, with GAAP EPS at $1.24 and adjusted non-GAAP EPS at $1.39. The company's adjusted EBITDA was $54.1 million, and it maintains a debt-free balance sheet with over $240 million in net cash.

Innospec reported a decrease in revenue by 2% to $500.2 million. Net income increased to $41.4 million, with GAAP EPS at $1.65 and adjusted non-GAAP EPS at $1.75. The company generated $80.6 million in cash from operations and closed the quarter with $270.1 million in net cash.

Innospec reported Q4 2023 revenues of $494.7 million, a 3% decrease year-over-year. Net income was $37.8 million, or $1.51 per diluted share, compared to $25.5 million, or $1.02 per diluted share in the previous year. Adjusted non-GAAP EPS was $1.84, compared to $1.20 in the prior year. The company generated $72.4 million in cash from operating activities.

Innospec's Q3 2023 results showed a revenue decrease of 10% to $464.1 million, but net income increased slightly to $39.2 million, with GAAP EPS at $1.57 and adjusted non-GAAP EPS at $1.59. The company generated $58.1 million in cash from operations and closed the quarter with $207.2 million in net cash.

Innospec Inc. reported a 3% increase in revenue to $480.4 million with net income of $28.9 million, or $1.16 per diluted share. Adjusted non-GAAP EPS was $1.28. Strong cash generation led to cash from operating activities of $55.0 million and a net cash position of $165.9 million.

Innospec's first quarter results showed an 8% increase in revenue, driven by Oilfield Services' growth, offsetting challenges in Performance Chemicals. The company reported GAAP EPS of $1.33 and adjusted non-GAAP EPS of $1.38. Fuel Specialties' gross margins improved sequentially, although dampened by an inventory misappropriation in Brazil. The company maintains a strong financial position with $147.5 million in net cash.

Innospec reported a strong fourth quarter with a 24% increase in revenue to $510.7 million and net income of $25.5 million. Adjusted non-GAAP EPS was $1.20. The company highlighted strong operating income growth and margin improvement.

Innospec Inc. reported a robust third quarter with a 36% increase in total revenues, reaching $513.0 million, and a 60% growth in operating income. Net income rose to $38.7 million, with GAAP EPS at $1.55 and adjusted non-GAAP EPS at $1.74. The company's cash from operations was $39.8 million, and its net cash position improved to $100.5 million.

Innospec reported a strong second quarter with a 32% increase in revenues and a 25% increase in operating income compared to the same period last year. The company's performance was driven by volume growth and price/mix improvements across all businesses. GAAP EPS was $1.29, and adjusted non-GAAP EPS was $1.58.

Innospec Inc. announced its financial results for the first quarter ended March 31, 2022, with total revenues of $472.4 million, a 39% increase from the corresponding period last year. Net income for the quarter was $36.5 million, or $1.46 per diluted share, compared to $23.4 million, or 94 cents per diluted share, recorded last year. Adjusted non-GAAP EPS in the first quarter was $1.53 per diluted share, compared to $1.06 per diluted share a year ago.

Innospec Inc. reported a strong fourth quarter with total revenues of $413.2 million, a 33% increase compared to the same period last year. Net income was $23.9 million, or $0.96 per diluted share. Adjusted non-GAAP EPS was $1.30. The company generated $68.8 million in cash from operating activities and closed the year with a net cash position of $141.7 million.

Innospec Inc. reported a 42% increase in revenue to $376.1 million for Q3 2021, with net income rising to $23.4 million, or $0.94 per share. Adjusted non-GAAP EPS was $1.15. The company highlighted strong performance in Performance Chemicals, Fuel Specialties, and Oilfield Services, with increased operating income and margin expansion.

Innospec Inc. reported a strong second quarter in 2021, with a 45% increase in total revenues to $354.5 million compared to the previous year. Net income reached $22.4 million, a significant turnaround from a $39.7 million loss in the same period last year. Adjusted non-GAAP EPS was $1.30, compared to an adjusted loss per share of $0.18 a year ago.

Innospec Inc. reported a decrease in total revenues to $339.6 million, a net income of $23.4 million, and an adjusted non-GAAP EPS of $1.06 for the first quarter ended March 31, 2021. The company saw record sales in Performance Chemicals and sequential growth in Fuel Specialties and Oilfield Services. They also increased their semi-annual dividend by 10 percent.

Innospec Inc. reported a decrease in total revenues for Q4 2020 to $310.8 million, a 20% decrease compared to $390.7 million in Q4 2019. Net income was $22.6 million, or $0.91 per diluted share, compared to $31.1 million, or $1.26 per diluted share in the same quarter last year. Adjusted non-GAAP EPS was $1.27 per diluted share, compared to $1.47 per diluted share a year ago.

Innospec reported Q3 2020 financial results with net sales of $265.1 million and a net income of $12.7 million, or $0.51 per share. Adjusted non-GAAP EPS was $0.71. The company generated $55.5 million in cash from operating activities and closed the quarter with a net cash position of $66.0 million.

Innospec Inc. reported a challenging second quarter with a net loss of $39.7 million, or $1.62 per share, compared to a net income of $22.3 million, or $0.90 per share, in the same quarter last year. Total net sales were $244.9 million, a 32% decrease from $362.4 million in the corresponding quarter last year. Performance Chemicals performed well, but Fuel Specialties and Oilfield Services were negatively impacted by reduced demand. The company took restructuring and impairment charges, but cash generation remained positive.

Innospec's Q1 2020 results showed a 4% decrease in net sales to $372.3 million, but net income increased to $33.1 million, or $1.34 per diluted share. Adjusted non-GAAP EPS rose by 14% to $1.42. The company maintained liquidity with positive operating cash flow and held its semi-annual dividend at $0.52 per share.

Innospec reported Q4 2019 revenues of $390.7 million and net income of $31.1 million, or $1.26 per diluted share. Adjusted non-GAAP EPS was $1.47. The company's performance was impacted by supply disruptions in Fuel Specialties and higher share-based compensation costs, but Oilfield Services and Performance Chemicals performed strongly.